Actividad fibrinolítica y phenformín en el pie diabético
Abstract
Se realiza un estudio dirigido a conocer la frecuencia y distribución de la actividad fibrinolítica disminuida, en los pacientes con pie diabético, y a medir la efectividad del phenformín (diabefén) en su capacidad para normalizarla. La frecuencia de actividad fibrinolítica disminuida fue de 63,1%. Dicha frecuencia no guardaba relación con el tipo de lesión inicial (isquémica o neuroinfecciosa) ni con el sexo, la edad, la duración conocida y el tipo de tratamiento de la diabetes. El phenformín resultó inefectivo en su capacidad para elevar la actividad fibrinolítica y sí el adecuado para el control metabólico de la enfermedad de base.Downloads
Downloads
Published
How to Cite
Issue
Section
License
The Cuban Journal of Medicine protects the author's patrimonial rights. However, it is licensed under a Creative Commons Licensehttps://creativecommons.org/licenses/by-nc/4.0/deed.es_ES which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided that the primary source of publication is duly cited. The author always retains his moral rights.
You are free to:
- Share - copy and redistribute the material in any medium or format.
- Adapt - remix, transform and build upon the material
- The license cannot revoke these freedoms as long as you follow the terms of the license.
Under the following terms:
- Attribution - You must give proper credit, provide a link to the license, and indicate if changes have been made. You may do so in any reasonable manner, but not in such a way as to suggest that you or your use is supported by the licensor.
- Non-Commercial Purpose- You may not make use of the material for commercial purposes.
- No Additional Restrictions - You may not apply legal terms or technological measures that legally restrict others from making any use permitted by the license.
